IMPAD1 Gene Chondrodysplasia with Joint Dislocations GPAPP Type Genetic Test
Test Name: IMPAD1 Gene Chondrodysplasia with Joint Dislocations GPAPP Type Genetic Test
Components: NGS Technology
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Dysmorphology
Doctor: Pediatrics
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for IMPAD1 Gene Chondrodysplasia with Joint Dislocations, GPAPP Type NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IMPAD1 Gene Chondrodysplasia with Joint Dislocations, GPAPP Type NGS Genetic DNA Test gene IMPAD1
Test Details
The IMPAD1 gene is associated with a rare genetic disorder called chondrodysplasia with joint dislocations, GPAPP type. This disorder is characterized by abnormal bone development, leading to short stature and joint dislocations.
NGS (Next-Generation Sequencing) genetic testing refers to a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of chondrodysplasia with joint dislocations, GPAPP type, NGS genetic testing can be used to analyze the IMPAD1 gene for any mutations or variations that may be causing the disorder.
By identifying mutations in the IMPAD1 gene, NGS genetic testing can help diagnose individuals with chondrodysplasia with joint dislocations, GPAPP type and provide important information for genetic counseling and management of the condition. It can also be used for carrier testing in families with a history of the disorder.
It’s important to note that NGS genetic testing is typically performed by specialized laboratories and requires a healthcare provider’s order. A genetic counselor or medical geneticist can help determine if NGS genetic testing is appropriate for an individual based on their symptoms, family history, and clinical presentation.
| Test Name | IMPAD1 Gene Chondrodysplasia with joint dislocations GPAPP type Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Dysmorphology |
| Doctor | Pediatrics |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for IMPAD1 Gene Chondrodysplasia with joint dislocations, GPAPP type NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IMPAD1 Gene Chondrodysplasia with joint dislocations, GPAPP type NGS Genetic DNA Test gene IMPAD1 |
| Test Details |
The IMPAD1 gene is associated with a rare genetic disorder called chondrodysplasia with joint dislocations, GPAPP type. This disorder is characterized by abnormal bone development, leading to short stature and joint dislocations. NGS (Next-Generation Sequencing) genetic testing refers to a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of chondrodysplasia with joint dislocations, GPAPP type, NGS genetic testing can be used to analyze the IMPAD1 gene for any mutations or variations that may be causing the disorder. By identifying mutations in the IMPAD1 gene, NGS genetic testing can help diagnose individuals with chondrodysplasia with joint dislocations, GPAPP type and provide important information for genetic counseling and management of the condition. It can also be used for carrier testing in families with a history of the disorder. It’s important to note that NGS genetic testing is typically performed by specialized laboratories and requires a healthcare provider’s order. A genetic counselor or medical geneticist can help determine if NGS genetic testing is appropriate for an individual based on their symptoms, family history, and clinical presentation. |
